Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
04/2012
04/25/2012CN101849953B 炎症性细胞因子产生游离抑制剂 Inflammatory cytokine production inhibitor free
04/25/2012CN101791348B 一种治疗虚损病的中药制剂 A treatment for wasting disease in Chinese medicine
04/25/2012CN101747432B 一种α1-抗胰蛋白酶药物的制备方法 One kind of α1- antitrypsin preparation of drugs
04/25/2012CN101732407B 田基黄复方制剂及其制备方法和应用 Hypericum compound and its preparation method and application
04/25/2012CN101690612B 含烟草的中草药保健烟 Tobacco smoke contains herbal health
04/25/2012CN101664390B 一种前列地尔脂微球的制备方法 One kind of alprostadil lipid microsphere preparation
04/25/2012CN101574445B 一种具有口腔保健功效的中药组合物 Chinese medicine composition with the efficacy of oral health
04/25/2012CN101574395B 一种采用高电压脉冲电场技术生产五味子提取物的方法 A method using high voltage pulsed electric field technology to produce extracts of Schisandra
04/25/2012CN101559192B 温中和胃的中药颗粒剂 Temperature and stomach medicine granules
04/25/2012CN101548946B 姜黄素纳米脂质注射液、其制备方法及用途 Curcumin Nanoliposomal injection, their preparation and use
04/25/2012CN101524394B 雀嘴茶制剂及其应用 Sparrow mouth tea preparation and its application
04/25/2012CN101503457B 柱层析peg与干扰素类似物蛋白氮端定点偶联方法及其产物 Column chromatography peg interferon analog protein nitrogen end point coupling methods and their products
04/25/2012CN101449825B 天然植物饮料 Natural plant beverage
04/25/2012CN101396115B 一种低聚木糖健胃润肠口服液及其制备方法 One kind of stomach and intestines XOS oral and preparation method
04/25/2012CN101378720B Fluoride composition and methods for dental mineralization
04/25/2012CN101341965B 肝炎、肝硬化患者食用的健康调料 Hepatitis, cirrhosis of the liver in patients with eating healthy seasoning
04/25/2012CN101273773B 一种具有保健功能的中草药调味酱油 An herbal seasoning sauce with health care function
04/25/2012CN101199615B 一种治疗口腔溃疡的外用内服口腔崩解片及其制备方法 A method of treating mouth ulcers topical oral orally disintegrating tablets and its preparation method
04/25/2012CN101032559B 益心健脾中成药的制备方法 Yixin spleen preparation of proprietary Chinese medicines
04/24/2012US8163751 Acylated indanyl amines and their use as pharmaceuticals
04/24/2012US8163733 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
04/24/2012US8163719 Regulators of the hedgehog pathway, compositions and uses related thereto
04/24/2012CA2700314C Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists
04/24/2012CA2645467C Pyridine derivative having anti-helicobacter pylori activity
04/24/2012CA2534259C Glycyrrhizin high-concentration preparation
04/24/2012CA2486537C 4-(substituted cycloalkylmethyl)imidazole-2-thiones, 4-(substituted cycloalkenylmethyl)imidazole-2-thiones, 4-(substituted cycloalkylmethyl)imidazol-2-ones and 4-(substituted cycloalkenylmethyl)imidazol-2-ones and related compounds
04/24/2012CA2452447C Antagonistic anti-htnfsf13b human antibodies
04/24/2012CA2447376C Prebiotic and probiotic compositions and methods for their use in gut-based therapies
04/24/2012CA2433807C Hydrophobic polyamine analogs and methods for their use
04/24/2012CA2433582C Peptides having inhibiting activity on the production of nitric oxide
04/24/2012CA2425599C Fumaric acid amides
04/24/2012CA2339529C Isolated and purified human soluble guanylyl cyclase .alpha.1/.beta.1 (hsgc .alpha.1/.beta.1)
04/19/2012WO2012050922A2 Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract
04/19/2012WO2012050589A1 Methods for treating hyperuricemia and related diseases
04/19/2012WO2012050184A1 Sustained-release pharmaceutical composition
04/19/2012WO2012050151A1 Acylbenzene derivative
04/19/2012WO2012050025A1 Medical adsorbent and method for producing same
04/19/2012WO2012049503A1 Algae-derived feed additive
04/19/2012WO2012049366A1 Norovirus capsid and rotavirus vp6 protein for use as combined vaccine
04/19/2012WO2012048470A1 Small molecular ribonucleic acid complexes from mammals
04/19/2012WO2012024519A3 Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues
04/19/2012WO2012017385A3 Beclomethasone dipropionate compositions in modified-release gastro-resistant microspheres and process for obtaining them
04/19/2012WO2012010974A3 Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia
04/19/2012WO2012002654A3 Natural food composition for treating constipation in weak-bladder body type person
04/19/2012WO2011139118A3 A pharmaceutical composition and a health functional food composition for preventing, treating or improving a gastrointestinal dyskinetic disease
04/19/2012WO2011138797A3 Delayed release oral disintegrating pharmaceutical compositions of lansoprazole
04/19/2012US20120096569 Anti-il-6 antibodies,compositions, methods and uses
04/19/2012US20120095102 Salts of 3-Pentylphenylacetic Acid and Pharmaceutical Uses Thereof
04/19/2012US20120095081 Treatment of paraoxonase 1 (pon1) related diseases by inhibition of natural antisense transcript to pon1
04/19/2012US20120095071 3-(3-indolyl) propionic acid calcium salt and method of making 3-(3-indolyl) propionic acid free acid therefrom
04/19/2012US20120095062 Tricyclic compounds, compositions, and methods
04/19/2012US20120095057 Pyrazole compound
04/19/2012US20120095056 2,5-disubstituted tetrazole derivatives and their use as nicotinic acetylcholine receptor modulators
04/19/2012US20120095055 HEXAHYDROCYCLOPENTYL[f]INDAZOLE 5-HYDROXYMETHYL ETHANOLS AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
04/19/2012US20120095047 Novel Heteropyrrole Analogs Acting on Cannabinoid Receptors
04/19/2012US20120095046 Amido-Isothiazole Compounds and Their Use as Inhibitors of 11Beta-HSD1 for the Treatment of Metabolic Syndrome and Related Disorders
04/19/2012US20120095040 Cyclopenta[c]pyrrole-2-carboxylate derivatives, preparation thereof and therapeutic use thereof
04/19/2012US20120095033 Selective Glycosidase Inhibitors and Uses Thereof
04/19/2012US20120095028 3-oxa-7-azabicyclo[3.3.1]nonanes
04/19/2012US20120095025 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
04/19/2012US20120095024 Toluidine sulfonamides and their use
04/19/2012US20120095012 Toluidine sulfonamides and their use
04/19/2012US20120095005 Fused Bicyclic Pyrazole Derivatives As Kinase Inhibitors
04/19/2012US20120095004 Sphingosine Kinase Inhibitors
04/19/2012US20120095003 Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof
04/19/2012US20120094990 Phenylacetic acid compound
04/19/2012US20120094989 5-ht receptor modulating compounds
04/19/2012US20120094987 SUBSTITUTED PYRIDO [3', 2': 4, 5] THIENO [3, 2-D] PYRIMIDINES AND PYRIDO [3', 2': 4, 5] FURO [3, 2-D] PYRIMIDINES USED AS INHIBITORS OF THE PDE-4 AND/OR THE RELEASE OF TNF-alpha
04/19/2012US20120094979 Thiazole or thiadizaloe derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists
04/19/2012US20120094972 Heterocyclic compounds and their uses
04/19/2012US20120094970 NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE
04/19/2012US20120094964 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
04/19/2012US20120094963 Targeting prodrugs and compositions for the treatment of gastrointestinal diseases
04/19/2012US20120094959 Treatment of cystic diseases
04/19/2012US20120094957 Inhibitors of fatty acid amide hydrolase
04/19/2012US20120094948 Analogous Compounds of 6-Thioguanosine Triphosphate, their use in Medical Fields and Processes for their Preparation
04/19/2012US20120094944 Novel imidazopyridine compound
04/19/2012US20120094942 Chemosensory Receptor Ligand-Based Therapies
04/19/2012US20120094941 Mangiferin-Berberine Salt, Manufacturing Method and Use Thereof
04/19/2012US20120094938 Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease
04/19/2012US20120094934 Treatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2
04/19/2012US20120094933 Derivatives of apf and methods of use
04/19/2012US20120094931 Compositions and methods to modulate progression and onset of inflammatory bowel disease
04/19/2012US20120094904 Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof
04/19/2012US20120094901 Method for controlling the digestive coagulation of proteins
04/19/2012US20120094897 Novel inhibitors of hepatitis c virus replication
04/19/2012US20120094894 Antidiabetic medications comprising a dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetics
04/19/2012US20120094893 Method of using diketopiperazines and composition containing them
04/19/2012US20120093938 Orally disintegrating tablets comprising diphenhydramine
04/19/2012US20120093937 Encapsulated liver cell composition
04/19/2012US20120093936 Method and device for treatment of conditions associated with inflammation or undesirable activation of the immune system
04/19/2012US20120093931 Inhibition of Neovascularization by Cerium Oxide Nanoparticles
04/19/2012US20120093915 Vectors including an anionic macromolecule and a cationic lipid for delivering small nucleic acids
04/19/2012US20120093898 Metal Ion Nanoclusters
04/19/2012US20120093888 micro-emulsions for the treatment of rheumatic disorders
04/19/2012US20120093887 Amorphous varenicline tartrate co-precipitates
04/19/2012US20120093885 Therapeutic vesicles
04/19/2012US20120093829 New methods for treatment of inflammatory diseases
04/19/2012US20120093810 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
04/19/2012US20120093783 Use adipose tissue-derived regenerative cells in the modulation of inflammation in the pancreas and in the kidney
1 ... 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 ... 1258